Integramed America, Inc. (INMD) Misses Q2 EPS by 10c

Integramed America, Inc. (NASDAQ: INMD) reported Q2 EPS of $0.04, $0.10 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $76.19 million versus the consensus estimate of $76.05 million.

For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• UBS Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
• Hyperion DeFi (HYPD) Tops Q2 EPS by 57c